Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical
Bull Case

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

• Intuitive Surgical, Inc. demonstrated strong fundamental performance in its most recent quarter, reporting earnings per share of $3.00, which significantly exceeded the analyst consensus estimate of $2.65, while revenue of $3.05 billion also surpassed expectations of $2.91 billion, indicating robust demand for its robotic-assisted systems.
• The company is experiencing accelerated growth in its installed base, with third-quarter system placements rising 28% year over year to 546 systems and net placements growing 40%, suggesting that hospitals are actively expanding their capacity for minimally invasive procedures rather than just replacing existing equipment.
• Despite recent volatility, the stock is trading at $468.52, which remains below the average analyst price target of $493.54 and the consensus rating of Moderate Buy, implying that the current valuation may still offer upside potential relative to sell-side expectations.
• Intuitive Surgical, Inc. maintains a dominant market position in the healthcare equipment sector, with its da Vinci Surgical System and Ion endoluminal system providing a diversified revenue stream that supports a high net margin of 25.54% and a return on equity of 18.17% in the latest reported period.
• Recent institutional activity shows continued interest from major investors, such as Rakuten Investment Management Inc. increasing its holdings by 10.2% and Capital Investment Services of America Inc. acquiring a new position of 30,207 shares, which can signal confidence in the company's long-term trajectory.